A Multi-centered，Randomized，Double-blind，Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in Eosinophilic Asthma

This study is testing a new drug called SHR-1703 for people with eosinophilic asthma — a type of asthma driven by high levels of a white blood cell called eosinophils — that is not well controlled despite being on multiple inhaler medicines. **You may be eligible if...** - You are 12 or older and weigh at least 40 kg (about 88 lbs) - You have had asthma for at least 1 year - You are on medium or high-dose inhaled corticosteroids (ICS) plus at least one other controller medication - Your blood eosinophil count is elevated (consistent with eosinophilic asthma) - Your asthma is poorly controlled and you had at least one severe flare-up in the past year - Your lung function testing (FEV1) shows reduced airflow **You may NOT be eligible if...** - Your asthma is well-controlled on current medications - Your eosinophil count is not elevated - You are pregnant or breastfeeding - You have certain other serious lung or immune conditions Talk to your doctor to see if this trial is right for you.